Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial-Reference-Cited by-同舟云学术

Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial

Published:2017-10-24 Issue:4 Volume:18 Page:927-935
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Moreso Francesc¹,Crespo Marta²,Ruiz Juan C.³^ORCID,Torres Armando⁴,Gutierrez-Dalmau Alex⁵,Osuna Antonio⁶,Perelló Manel¹,Pascual Julio²,Torres Irina B.¹,Redondo-Pachón Dolores²,Rodrigo Emilio³,Lopez-Hoyos Marcos⁷,Seron Daniel¹

Affiliation:

1. Nephrology Department; Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona; Barcelona Spain

2. Nephrology Department; Hospital del Mar, Parc de Salut Mar; Barcelona Spain

3. Nephrology Department; Hospital Universitario Marqués de Valdecilla; Santander Spain

4. Nephrology Department; Hospital Universitario de Canarias; La Laguna Spain

5. Nephrology Department; Hospital Universitario Miguel Servet; Zaragoza Spain

6. Nephrology Department; Hospital Universitario Virgen de las Nieves; Granada Spain

7. Immunology Department; Hospital Universitario Marqués de Valdecilla; Santander Spain

Funder

Spanish Ministery of Health

Red de Investigación Renal REDinREN

Publisher